LIC announced on Thursday that it had sold 2 percent of its stake in Sun Pharma for Rs 4,699 crore in an open market transaction.
Following the share sale, there is a decrease of 2 percent decline in holding between July 22, 2022, and September 13, 2023.
In a regulatory filing, LIC stated, “Corporation’s shareholding in Sun Pharma has diluted from 12,05,24,944 to 7,22,68,890 equity shares decreasing its shareholding from 5.023 percent to 3.012 percent of the paid-up capital of the said company”.
“The shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction”, LIC added.
Sun Pharma manufactures, develops, and markets a diverse range of branded and generic formulations, as well as Active Pharma Ingredients (APIs).
LIC, the country’s largest state-owned insurer, finished at Rs 660.80 per share on BSE, up 0.27 percent. Sun Pharma shares closed 0.8 percent higher at Rs 1,143.60.
Also read: Maruti Suzuki Collaborates With Indian Bank To Offer Dealers Financing Options
The Mumbai Police disclosed that the firearms used to assassinate late NCP leader Baba Siddiqui…
Mumbai Police is investigating a threatening message directed at actor Salman Khan, allegedly originating from…
Ahead of the by-elections, CM Yogi Adityanath's government in Uttar Pradesh will take greater control…
Somy Ali, the former Bollywood actress and dedicated social worker, has shared her feelings about…
External Affairs Minister S Jaishankar expressed grave concerns regarding the recent violent incident at a…
The Sensex slipped slightly by 68.22 points, or 0.09%, to trade at 78,714.02, while the…